ProductLife Group (PLG), the global provider of regulatory, vigilance and quality services for the Pharmaceutical, Medtech and Biotech industries announces the acquisition of Zwiers Regulatory Consultancy – a consultancy specialising in regulatory affairs, pharmacovigilance and integrated development for drugs and devices with offices in Amsterdam and Oss, the Netherlands.
Since 2011, Zwiers Regulatory Consultancy has established a reputation as a strategic partner in the life sciences industry. It offers integrated product development services in the EU, the US and other territories, covering early and late stage strategic, scientific, and regulatory support up to dossiers submission and beyond, to ensure compliance throughout the product life cycle. Through this acquisition, PLG immediately expands and substantially enhances its comprehensive suite of drug development services and medical device expertise. This footprint expansion in the dynamic Dutch life science ecosystem and physical proximity to the European Medicines Agency (EMA) will bolster PLG’s ability to provide its clients with global support.
Led by Founder and CEO, Alex Zwiers – an experienced industry professional (previously employed at Organon and Merck) – Zwiers Regulatory Consultancy has expanded by working with innovative and creative companies supporting them in the optimal regulatory path to obtain and maintain registration. Apart from providing strategic advice, the consultancy’s service covers medical and regulatory writing, building and submitting dossiers, preparing and executing pharmacovigilance systems, initiating and supporting health authority interactions, coordinating and smoothening procedures, writing and updating labelling.
“I see this as a very welcome partnership with us joining a large PLG family of like-minded people,” said Alex Zwiers. “Under the PLG brand, we can offer an even more complete package of high quality services. Bundling our complementary activities with an organisation of excellent reputation like PLG, will enable us to extend our experience and creativity for the benefit of clients and their patients .
Xavier Duburcq, CEO at PLG said, “With the leadership of Alex Zwiers and his successful team, expanding our global coverage, we are confident in PLG’s ability to support our clients in their complex development programmes. This alliance will unlock meaningful potential and reinforce our ability to positively contribute to regulatory assessment, scientific progress, and launch of successful treatments.”